Abstract:Background Despite the European Society of Cardiology (ESC) guidelines advocating risk prediction models for secondary prevention in established atherosclerotic cardiovascular disease (ASCVD) patients, such models for Japanese individuals remain limited, owing to their comparatively lower ASCVD risk than Western populations. Given this gap, there is a need to develop tailored risk assessment tools for Japanese ASCVD patients to optimize secondary prevention strategies. Purpose Leveraging data from two large-scale, long-term cardiovascular cohorts in Japan, our aim was to develop and externally validate a 10-year risk model predicting recurrent cardiovascular events among patients with established ASCVD. Methods The CHART-2 and Suita studies, large-scale prospective observational multicenter cohort studies in Japan, served as the primary data sources for this investigation. From the CHART-2 study, which comprised 3,560 patients with a history of coronary artery disease or ischemic stroke, we derived our risk model. External validation was conducted using data from the Suita study, which included 445 patients with similar ASCVD backgrounds. The primary outcome of interest was a composite endpoint encompassing cardiovascular death, myocardial infarction, or stroke. Variable selection was performed based on clinically relevant factors previously employed in established risk scores (SMART, REACH, and TRS 2°P risk scores). Logistic regression was utilized for model development, and the predictive performance was assessed using the C-index. Results Over a median follow-up of 10.1 years, the derivation cohort experienced 756 cardiovascular events. Patients in the derivation cohort had an average age of 68.9 ± 10.6 years, with 91% and 24% having a history of coronary artery disease and ischemic stroke, respectively. Using logistic regression, the multivariate model revealed a higher recurrent risk associated with several factors including age, smoking status, systolic blood pressure, diabetes, renal function, number of ASCVD events, atrial fibrillation, lipid levels, left ventricular systolic dysfunction, and statin use. A simple risk score based on these predictors demonstrated a >5-fold gradient of 10-year recurrent risk with a C-index of 0.65 (95% CI 0.63-0.68, Figure). The prediction model was externally validated in the Suita study wit 245 cardiovascular events and a median follow-up of 10.4 years, showing good discriminative ability with a C-index of 0.64 (95% CI 0.60–0.68). Conclusion Our newly developed prediction model offers a valuable tool for identifying individuals at heightened risk of recurrent cardiovascular events over a 10-year period, thereby facilitating more targeted and effective secondary prevention strategies tailored to the unique characteristics of Japanese ASCVD patients.

Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study

Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham risk score: the Suita study

Development of a cardiovascular disease risk prediction model using the Suita Study, a population-based prospective cohort study in Japan

Comparison of MESA of and Framingham Risk Scores in the Prediction of Coronary Artery Disease Severity

Comparison of Machine Learning Models and Framingham Risk Score for the prediction of the presence and severity of Coronary Artery Diseases by using Gensini Score

Exploring the Utility of the Reynolds and Framingham Risk Stratification Models in Predicting the Presence and Severity of Coronary Artery Disease in Chinese Patients

Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study

Prediction of 10-year risk for recurrent atherosclerotic cardiovascular events in a secondary prevention population: Insights from CHART-2 and Suita studies in the Japanese population

Developing a stroke risk prediction model using cardiovascular risk factors: the Suita Study

Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population―The Suita Study―

Development of a risk equation for the incidence of coronary artery disease and ischemic stroke for middle-aged Japanese–Japan Public Health Center-Based Prospective Study–

Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study

MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden

Framingham Risk Score for the Prediction of Coronary Artery Disease in Patients with Chronic Rheumatic Heart Disease

Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study

Development, Validation and Comparison of Multivariable Risk Scores for Prediction of Total Stroke and Stroke Types in Chinese Adults: a Prospective Study of 0.5 Million Adults

[Role of Novel Risk Factors in Predicting Risk of Ischemic Cardiovascular Diseases in Middle Aged Men in Twenty Years in Shanghai].

Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes

Comparisons of the Framingham and ASCVD Risk Scores for Coronary Heart Disease Risk Prediction in Chinese Men

Significance of coronary artery calcification for predicting major adverse cardiovascular events: results from the NADESICO study in Japan